Saurabh Dahiya
Clinical Director of Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy · Stanford University School of Medicine
Credentials: · · · · · · · ·
History
PresentCell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy · Stanford University School of Medicine
Until 2017- Until 2016
Until 2013- Until 2012
- Until 2010
Research
Journal of Clinical Oncology · 2020 · 691 citations
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
Case report · New England Journal of Medicine · 2024 · 183 citations
Journal of Clinical Oncology · 2023 · 178 citations
40 papers
29 papers
27 papers
25 papers
22 papers
17 papers
- FL
17 papers · 8 as a fellow
16 papers
Clinical trials
- 2026–2041
Autoimmune Cytopenia Elimination by Chimeric Antigen Receptor T-cell Therapy
Principal investigator · Not yet recruiting · Phase 1
Saurabh Dahiya
- 2026–2028
CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
Principal investigator · Not yet recruiting · Phase 1
Stanford University
- 2023–2038
Principal investigator · Recruiting · Phase 1
Stanford University
- 2024–2029
Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL
Sub-investigator · Recruiting · Phase 2
H. Lee Moffitt Cancer Center and Research Institute